31
Publications
6.6K
Citations
28
H-Index
1991
Active since
Gregory R. Hoffman is an author at Novartis (Switzerland) specializing in medicine, cell biology, and cell signaling.
Top concepts
MedicineCell BiologyCell SignalingMolecular BiologySignal TransductionImmunologySystems BiologyNatural SciencesCellular BiochemistryCrispr
Publications per year
1991–2021
31
31
p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells
Robert J. Ihry, Kathleen A. Worringer, Max R. Salick et al. · Nature Medicine · 2018 · 988 citations
DNA Repair Profiling Reveals Nonrandom Outcomes at Cas9-Mediated Breaks
Megan van Overbeek, Daniel Capurso, Matthew M. Carter et al. · Molecular Cell · 2016 · 494 citations · Full text
Rows per page
1–5 of 31